Biodesix core revenue grows 52% year-over-year

BOULDER — Biodesix Inc. (Nasdaq: BDSX) experienced 52% year-over-year core revenue growth for the second quarter of 2022, the company reported Friday. The life sciences company reported $7.3 million in … Continued
Source: BizWest

Related Articles